Patents by Inventor Masakazu Iwai

Masakazu Iwai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5264681
    Abstract: The invention relates to a ceramic heater for use, e.g., as a glow plug for a diesel engine or as an igniter for an oil or gas burner. The ceramic heater has a nonoxide ceramic body having a heating part and a supporting part and a heating resistor embedded in the heating part of the ceramic body. The material of the heating resistor is W, WC, tungsten alloy or a metal nitride such as TiN or TaN. According to the invention the heating part of the ceramic body is formed of aluminum nitride ceramic, which is high in heat conductivity and resistant to oxidation at high temperatures, at least in a core region in contact with the heating resistor, and the supporting part is formed of silicon nitride ceramic which is low in heat conductivity at least in a surface region.
    Type: Grant
    Filed: February 7, 1992
    Date of Patent: November 23, 1993
    Assignee: NGK Spark Plug Co., Ltd.
    Inventors: Shunkichi Nozaki, Yasuhiko Suzuki, Kazuho Tatematsu, Masakazu Iwai, Kiminori Horiki
  • Patent number: 5053498
    Abstract: A therapeutic and prophylactic agent for peptic ulcers which contains as an active ingredient a compound of the general formula (I): ##STR1## wherein R.sub.1 represents hydrogen or .dbd.O; R.sub.2 represents hydrogen or --OR.sub.5 ; R.sub.3 represents hydrogen or --OR.sub.5 ; R.sub.4 represents --OR.sub.7 in the case of the absence of double bond; R.sub.5, R.sub.6 and R.sub.7 each represents hydrogen or an organic residue;X represents group (A);.dbd.C.dbd.CH--COR.sub.8 (A)or group (B): ##STR2## wherein R.sub.8 represents alkyl, and R.sub.9 and R.sub.10 each represents hydrogen or an organic residue; with the proviso that when X represents group (A), then R.sub.1 and R.sub.3 both represent hydrogen, R.sub.2 represents --OR.sub.5, R.sub.4 represents OR.sub.7 and the bond between the carbon atom to which X is attached and the carbon atom to which R.sub.4 is attached is a single bond, and when X represents group (B), then R.sub.1 represents .dbd.O, R.sub.2 represents hydrogen, R.sub.3 represents --OR.sub.
    Type: Grant
    Filed: October 16, 1989
    Date of Patent: October 1, 1991
    Assignee: Green Cross Corporation
    Inventors: Yusei Shiraga, Chikara Fukaya, Toshiaki Akira, Masakazu Iwai, Kazumasa Yokoyama, Mamoru Tabata, Hiroshi Fukui, Shigeo Tanaka, Yoshiro Iga, Tadakazu Suyama, Kanemichi Okano
  • Patent number: 4983584
    Abstract: A therapeutic and prophylactic agent for peptic ulcers comprising as an effective ingredient a cyclohexane derivative represented by general formula (I): ##STR1## wherein A represents a group shown by formula, >CH.sub.2, ##STR2## wherein X represents ethynylene, vinylene or ethylene, Y represents oxo or a hydroxy group; R.sup.1, R.sup.3, R.sup.4 and R.sup.5 each represents a hydrogen atom or alkyl; R.sup.2 represents a hydrogen atom, alkyl or a group shown by --OR.sup.8 ;R.sup.6 represents a hydrogen atom, oxo or a group shown by --OR.sup.8 ; and R.sup.7 represents a hydrogen atom or a group shown by --OR.sup.8, wherein R.sup.8 represents a hydrogen atom or an organic residue.
    Type: Grant
    Filed: November 23, 1987
    Date of Patent: January 8, 1991
    Assignee: Green Cross Corporation
    Inventors: Chikara Fukaya, Hitoshi Yasuda, Toshiaki Akira, Masakazu Iwai, Kanemichi Okano, Kazumasa Yokoyama
  • Patent number: 4916130
    Abstract: An antithrombotic composition containing an amide derivative which is obtained by binding a sulfur-containing amine to an unsaturated fatty acid having 4 to 13 carbon atoms through an amide bond and which exerts a high platelet agglutination-inhibiting effect.
    Type: Grant
    Filed: September 8, 1988
    Date of Patent: April 10, 1990
    Assignee: Green Cross Corporation
    Inventors: Masakazu Iwai, Chikara Fukaya, Kazumasa Yokoyama
  • Patent number: 4888417
    Abstract: A therapeutic and prophylactic agent for peptic ulcers which contains as an active ingredient a compound of the general formula (I): ##STR1## wherein R.sub.1 represents hydrogen or =O; R.sub.2 represents hydrogen or --OR.sub.5 ; R.sub.3 represents hydrogen or --OR.sub.6 ; R.sub.4 represents --OR.sub.7 in the case of the absence of double bond; R.sub.5, R.sub.6 and R.sub.7 each represents hydrogen or an organic residue;X represents group (A):.dbd.C.dbd.CH--COR.sub.8 (A)or group (B): ##STR2## wherein R.sub.8 represents alkyl, and R.sub.9 and R.sub.10 each represents hydrogen or an organic residue; with the proviso that when X represents group (A), then R.sub.1 and R.sub.3 both represent hydrogen, R.sub.2 represents --OR.sub.5 ; R.sub.4 represents OR.sub.7 and the bond between the carbon atoms to which X is attached and the carbon atom to which R.sub.4 is attached is a single bond, and when X represents group (B), then R.sub.1 represents .dbd.O, R.sub.2 represents hydrogen, R.sub.3 represents --OR.sub.
    Type: Grant
    Filed: May 27, 1986
    Date of Patent: December 19, 1989
    Assignee: Green Cross Corporation
    Inventors: Yusei Shiraga, Chikara Fukaya, Toshiaki Akira, Masakazu Iwai, Kazumasa Yokoyama, Mamoru Tabata, Hiroshi Fukui, Shigeo Tanaka, Yoshiro Iga, Tadakazu Suyama, Kanemichi Okano
  • Patent number: 4849404
    Abstract: Fab or Fc fragment of human IgG which is obtainable by enzymatic digestion of the human IgG is reduced by a reducing agent to sever an interchain of disulfide bonds therein and then blocked the SH radicals formed with alkyl group which may contain other groups. The resulting alkylated Fab and Fc fragments display therapeutic and prophylactic action for gastrointestinal ulcers by the oral or parenteral administration.
    Type: Grant
    Filed: March 3, 1988
    Date of Patent: July 18, 1989
    Assignee: The Green Cross Corporation
    Inventors: Masakazu Iwai, Kazumasa Yokoyama, Tsunekazu Fukushima
  • Patent number: 4748157
    Abstract: Fab or Fc fragment of human IgG which is obtainable by enzymatic digestion of the human IgG is reduced by a reducing agent to sever an interchain of disulfide bonds therein and then blocked the SH radicals formed with alkyl group which may contain other group. The resulting alkylated Fab and Fc fragments display therapeutic and prophylactic action for gastrointestinal ulcers by the oral or parenteral administration.
    Type: Grant
    Filed: February 4, 1986
    Date of Patent: May 31, 1988
    Assignee: The Green Cross Corporation
    Inventors: Masakazu Iwai, Kazumasa Yokoyama, Tsunekazu Fukushima
  • Patent number: 4186253
    Abstract: An organ to be transplanted, such as kidney, can effectively be preserved by perfusion for a considerably long time by the use of a perfusate which is made by mixing a Ringer's solution modified by increasing potassium ion to 8-20 meq/l, a stable perfluorocarbon compound emulsion and albumin, so that the concentration of the perfluorocarbon compound is 7.5 to 12.5% (W/V) and that of albumin is 1-8% (W/V) based on the perfusate.
    Type: Grant
    Filed: October 10, 1978
    Date of Patent: January 29, 1980
    Assignee: The Green Cross Corporation
    Inventors: Kazumasa Yokoyama, Masakazu Iwai, Hiroyuki Okamoto, Noboru Yamada